NCT06943989View on ClinicalTrials.gov

Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air at Rest

NAEnrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Lung InflammationExperimental Lung Inflammation
Interventions
OTHER

Ozone Exposure

6.6 hour exposure to 0.07 ppm ozone while at rest

OTHER

Clean air (0.0 ppm ozone)

6.6 hour exposure to clean air (0.00 ppm ozone) while at rest

Trial Locations (1)

27514

EPA Human Studies Facility, Chapel Hill

All Listed Sponsors
lead

Environmental Protection Agency (EPA)

FED